Experts say the deal to lower the cost of the drugs is ambitious, but left some with more questions than answers.

A Trump administration deal to cut prices for popular weight-loss drugs like Wegovy and Zepbound will allow millions more ...

Virtual weight management was associated with significantly weight loss at 6, 12, and 18 months among patients with obesity and with or without T2D.

Novo Nordisk and Eli Lilly said they've agreed to sell their blockbuster drugs Wegovy and Zepbound at a discount.

Millions of Americans will soon have direct access to popular weight-loss drugs at far lower prices than they pay now. That’s ...

President Trump announced a deal on Thursday that will lower the cost of some weight loss drugs for certain eligible ...

Beverley O'Hara is affiliated with The Association for the Study of Obesity. Jordan Beaumont receives funding from NIHR. He is affiliated with the Association for the Study of Obesity. But while these ...

Zepbound (tirzepatide) and Wegovy (semaglutide) are FDA-approved injectable medications revolutionizing weight management. Both belong to the incretin mimetic drug class but differ in their mechanisms ...

The Gates Foundation is exploring ways to make weight-loss drugs more accessible in lower-income countries. Bill Gates told Reuters that his foundation would take any drug that was effective in ...

Microdosing GLP-1 weight loss drugs like semaglutide is trendy, with supporters touting benefits such as lower costs and potentially fewer side effects. But some doctors are skeptical, calling it ...

Oct 23 (Reuters) - London-based telehealth startup SheMed said on Thursday it raised $50 million in a Series A round, valuing the company at $1 billion, as demand for weight-loss drugs Wegovy and ...

GLP-1s may shrink the scale, but they can also shrink your muscle, especially your heart. When you stop the meds, dangerous belly fat often comes back fast and harder than before. Dr. Sean O’Mara ...